Internal Medicine, Cardiovascular Disease · Ocala, FL
NPI
1295938975
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3310 SW 34th St
Ocala, FL, 34474
Phone (352) 873-9557
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
17,215 services
Medicare patients, 2024
2,572
Average age 76
Drug cost, 2024
$5.3M
25,729 prescriptions
Company payments, 2025
$1,081
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lan Luo was code 99214 (office e&m - established), 5,784 times for 1,887 patients. In total Lan Luo billed 17,215 services in 75 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 5,784 | 1,887 | $92.68 | $536K |
| 99232 Hospital E&M - Subsequent | Facility | 1,327 | 354 | $61.90 | $82K |
| 93306 Echocardiography (TTE/TEE) | Office | 1,239 | 1,209 | $127.52 | $158K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,064 | 265 | $5.43 | $5,781 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 970 | 483 | $96.86 | $94K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 832 | 813 | $129.68 | $108K |
| 93000 Electrocardiogram | Office | 759 | 648 | $10.17 | $7,716 |
| 99223 Hospital E&M - Initial | Facility | 529 | 449 | $135.12 | $71K |
| 93015 Electrocardiogram | Office | 483 | 481 | $47.89 | $23K |
| 78452 Myocardial Perfusion Scan | Office | 483 | 481 | $317.68 | $153K |
| 93296 External Electrocardiographic Monitoring | Office | 444 | 190 | $15.12 | $6,715 |
| 93306 Echocardiography (TTE/TEE) | Facility | 406 | 389 | $52.73 | $21K |
| 93294 External Electrocardiographic Monitoring | Office | 359 | 151 | $21.79 | $7,821 |
| 99204 Office E&M - New | Office | 328 | 328 | $116.07 | $38K |
| 99215 Office E&M - Established | Office | 246 | 219 | $128.79 | $32K |
By year: 2022 $1.6M for 15,708 services; 2023 $1.6M for 17,611 services; 2024 $1.5M for 17,215 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lan Luo prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,754 prescriptions and refills. In total Lan Luo wrote 25,729 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,754 | 4,173 | 545 | $20K |
| Losartan Potassium Generic | 1,662 | 4,116 | 487 | $15K |
| Metoprolol Tartrate Generic | 1,633 | 3,786 | 491 | $9,449 |
| Metoprolol Succinate Generic | 1,576 | 3,772 | 461 | $21K |
| Carvedilol Generic | 1,418 | 3,275 | 389 | $13K |
| Eliquis Apixaban | 1,411 | 2,480 | 344 | $1.4M |
| Amlodipine Besylate Generic | 1,345 | 3,235 | 408 | $7,494 |
| Atorvastatin Calcium Generic | 1,073 | 2,749 | 328 | $9,353 |
| Furosemide Generic | 932 | 2,024 | 330 | $4,046 |
| Ezetimibe Generic | 891 | 2,201 | 274 | $17K |
| Lisinopril Generic | 771 | 1,949 | 229 | $3,923 |
| Xarelto Rivaroxaban | 715 | 1,306 | 173 | $707K |
| Entresto Sacubitril/Valsartan | 591 | 1,123 | 147 | $702K |
| Clopidogrel Clopidogrel Bisulfate | 526 | 1,265 | 180 | $5,021 |
| Nitroglycerin Generic | 486 | 503 | 321 | $5,191 |
Brand drugs: - claims; generic drugs: 20,434 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lan Luo $1,081 ($1,081 in general payments such as food, travel and fees) from 24 companies. The largest payer was Pfizer Inc. with $104.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 4 | $104 |
| Philips North America LLC PHG | 3 | $82.83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75.59 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $73.74 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $70.48 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $70.2 |
| Abbott Laboratories ABT | 2 | $62.47 |
| United Therapeutics Corporation UTHR | 2 | $61.68 |
| Merck Sharp & Dohme LLC MRK | 3 | $60.62 |
| Esperion Therapeutics, Inc. ESPR | 3 | $54.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.